Skip to main content
. 2020 Nov 2;166(1):1–7. doi: 10.1007/s00705-020-04860-8

Fig. 2.

Fig. 2

Effect of tetracyclines on the NF-κB transcription factor pathway. Minocycline (Min) and doxycycline (Dox) are capable of inhibiting the NF-κB pathway, acting on different points of this activation by inhibiting IκBα (IKK) activation, IκBα phosphorylation, degradation and p65, and nuclear translocation of NF-κB, leading to a decreased pro-inflammatory immune response